Patients who survive a COVID ARDS in intensive care must be weaned off invasive mechanical ventilation as quickly as possible. 60% of these patients present with intensive care delirium research hub

Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID)

This study looks at how a medicine called dexmedetomidine might help reduce long-term brain inflammation in COVID-19 patients who were very ill and needed breathing support. It aims to see if this medicine can improve their brain health after leaving intensive care.